Christopher Bettacchi

466 total citations
10 papers, 120 citations indexed

About

Christopher Bettacchi is a scholar working on Infectious Diseases, Virology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christopher Bettacchi has authored 10 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Virology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christopher Bettacchi's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Christopher Bettacchi is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (6 papers) and HIV/AIDS Research and Interventions (3 papers). Christopher Bettacchi collaborates with scholars based in United States, Belgium and France. Christopher Bettacchi's co-authors include Alan M. Stamm, Stephanie O. Klopfer, Carey Hwang, Yazdan Yazdanpanah, Michael Robertson, Anjana Grandhi, Karen Eves, Jean‐Michel Molina, George J. Hanna and Peter Sklar and has published in prestigious journals such as The Lancet, Journal of Antimicrobial Chemotherapy and Journal of Shoulder and Elbow Surgery.

In The Last Decade

Christopher Bettacchi

10 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Bettacchi United States 6 90 67 26 19 15 10 120
David Dorey Canada 6 112 1.2× 74 1.1× 43 1.7× 19 1.0× 17 1.1× 10 156
Agathe Rami France 9 80 0.9× 75 1.1× 72 2.8× 17 0.9× 7 0.5× 10 175
Coca Necsoi Belgium 8 97 1.1× 77 1.1× 40 1.5× 53 2.8× 10 0.7× 23 146
Oon Tek Ng Singapore 8 106 1.2× 42 0.6× 68 2.6× 39 2.1× 7 0.5× 15 136
Laura Comi Italy 9 127 1.4× 91 1.4× 39 1.5× 32 1.7× 14 0.9× 29 180
Hylke Waalewijn Netherlands 4 79 0.9× 41 0.6× 37 1.4× 30 1.6× 6 0.4× 10 116
Abdulwasiu Bolaji Tiamiyu Nigeria 6 34 0.4× 34 0.5× 18 0.7× 8 0.4× 9 0.6× 14 118
Catherine Chakvetadze France 5 54 0.6× 18 0.3× 79 3.0× 8 0.4× 11 0.7× 14 127
Marcello Feasi Italy 8 34 0.4× 21 0.3× 56 2.2× 7 0.4× 7 0.5× 15 124
Ilaria Mastrorosa Italy 8 35 0.4× 36 0.5× 65 2.5× 23 1.2× 4 0.3× 22 142

Countries citing papers authored by Christopher Bettacchi

Since Specialization
Citations

This map shows the geographic impact of Christopher Bettacchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Bettacchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Bettacchi more than expected).

Fields of papers citing papers by Christopher Bettacchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Bettacchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Bettacchi. The network helps show where Christopher Bettacchi may publish in the future.

Co-authorship network of co-authors of Christopher Bettacchi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Bettacchi. A scholar is included among the top collaborators of Christopher Bettacchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Bettacchi. Christopher Bettacchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
McKellar, Mehri S., Christopher Bettacchi, Jonathan B. Angel, et al.. (2023). 1587. SOLAR 12-Month North American Results: Randomized Switch Trial of CAB+RPV LA vs. Oral BIC/FTC/TAF. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
3.
Lo, Eddie Y., et al.. (2022). Success of staged revision reverse total shoulder arthroplasty in eradication of periprosthetic joint infection. Journal of Shoulder and Elbow Surgery. 32(3). 625–635. 11 indexed citations
4.
5.
Molina, Jean‐Michel, Yazdan Yazdanpanah, Christopher Bettacchi, et al.. (2021). Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(1). 68–72. 15 indexed citations
6.
DeJesus, Edwin, Jean‐Michel Molina, Yazdan Yazdanpanah, et al.. (2020). Islatravir safety analysis through week 48 from a phase 2 trial in treatment naive adults with HIV-1 infection. Journal of the International AIDS Society. 2 indexed citations
7.
Molina, Jean‐Michel, Yazdan Yazdanpanah, Christopher Bettacchi, et al.. (2020). Islatravir in combination with doravirine maintains HIV-1 viral suppression through 96 weeks. Journal of the International AIDS Society. 8 indexed citations
8.
Smith, Graham, Keith Henry, Daniel Podzamczer, et al.. (2020). 638. Safety, Efficacy, and Durability of Long-Acting CAB and RPV as Maintenance Therapy for HIV-1 Infection: LATTE-2 Week 256 Results. Open Forum Infectious Diseases. 7(Supplement_1). S379–S380. 2 indexed citations
9.
Letendre, Scott, Anthony Mills, Debbie Hagins, et al.. (2019). Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults. Journal of Antimicrobial Chemotherapy. 75(3). 648–655. 22 indexed citations
10.
Stamm, Alan M. & Christopher Bettacchi. (2012). A comparison of 3 metrics to identify health care-associated infections. American Journal of Infection Control. 40(8). 688–691. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Dorey Breakdown of academic impact, for papers by Agathe Rami Breakdown of academic impact, for papers by Coca Necsoi Breakdown of academic impact, for papers by Oon Tek Ng Breakdown of academic impact, for papers by Laura Comi Breakdown of academic impact, for papers by Hylke Waalewijn Breakdown of academic impact, for papers by Abdulwasiu Bolaji Tiamiyu Breakdown of academic impact, for papers by Catherine Chakvetadze Breakdown of academic impact, for papers by Marcello Feasi Breakdown of academic impact, for papers by Ilaria Mastrorosa
Rankless by CCL
2026